These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5110306)

  • 1. Hepatitis and blood donors.
    Simmons A
    J Iowa Med Soc; 1971 Oct; 61(10):620-1. PubMed ID: 5110306
    [No Abstract]   [Full Text] [Related]  

  • 2. At last--a national blood policy?
    Aledort LM
    Hosp Pract; 1979 Jul; 14(7):11, 15. PubMed ID: 478506
    [No Abstract]   [Full Text] [Related]  

  • 3. AABB reacts to rise in hepatitis rates.
    Hospitals; 1971 Nov; 45(22):67-70. PubMed ID: 5128764
    [No Abstract]   [Full Text] [Related]  

  • 4. Commercially obtained blood and serum hepatitis.
    Allen JG
    Surg Gynecol Obstet; 1970 Aug; 131(2):277-81. PubMed ID: 5433844
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of viral hepatitis marker test methods based on AABB-CAP survey data.
    Polesky HF; Hanson MR
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):521-4. PubMed ID: 7282638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution of the Australia antigen in a group of blood donors from Genoa].
    Burlando L; Avanzi G
    Pathologica; 1970; 62(914):235-9. PubMed ID: 5524904
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing for hepatitis-associated antigen.
    Cavenaugh RL
    Md State Med J; 1971 Jul; 20(7):129-30. PubMed ID: 5565131
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of viral hepatitis and Australia antigen among the personnel of transfusion centers.
    Apăteanu V; Popovici C; Ricman T; Călăraşu E; Dacu M
    Rev Roum Inframicrobiol; 1971; 8(1):3-7. PubMed ID: 5164566
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present status of screening test for donor-carriers of viral hepatitis.
    R I Med J; 1971 Feb; 54(2):97-8. PubMed ID: 5276803
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of AU-SH carriers in a blood donor population. Results by immunodiffusion, electrosyneresis and complement fixation test.
    Rosanda C; Giuliani G; Franchini MI; Tonda GP; Novara O
    Pathologica; 1971; 63(923):219-21. PubMed ID: 5005230
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of isolated hepatitis B core antibody in blood donors.
    Schifman RB; Rivers SL; Sampliner RE; Krammes JE
    Arch Intern Med; 1993 Oct; 153(19):2261-6. PubMed ID: 8215729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient.
    Jongerius JM; van der Poel CL; van Leeuwen EF
    Vox Sang; 1998; 75(1):66-9. PubMed ID: 9745157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining the supply and monitoring the quality of the blood bank.
    Henry GW
    Hawaii Med J; 1992 Jan; 51(1):7. PubMed ID: 1740389
    [No Abstract]   [Full Text] [Related]  

  • 16. Reliability of measurements of serum alanine transaminase activity and the impact on the cut-off value for the selection of blood donors.
    Morisco F; Rosmini F
    Haematologica; 2002 May; 87(5):559-60. PubMed ID: 12010677
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis A virus prevalence in plasma donations.
    Weimer T; Streichert S; Watson C; Gröner A
    J Med Virol; 2002 Aug; 67(4):469-71. PubMed ID: 12115990
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of hepatitis B seroprevalence in blood banking units by combined utilization of self-exclusion forms and clinical evaluation of blood donation candidates in Turkey.
    Yenicesu I; Dilsiz G; Oztürk G
    Trop Doct; 2008 Apr; 38(2):112-3. PubMed ID: 18453509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
    Pahuja S; Sharma M; Baitha B; Jain M
    Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of donors and blood products reactive for hepatitis B virus DNA.
    Reesink HW; Allain JP
    Vox Sang; 2006 Nov; 91(4):281. PubMed ID: 17105601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.